Separately, Canaccord Genuity raised their price target on Aphria from C$8.25 to C$14.00 in a research report on Tuesday, December 5th.
Shares of Aphria (TSE APH) traded down C$2.53 during midday trading on Thursday, hitting C$18.02. The company had a trading volume of 11,210,000 shares, compared to its average volume of 5,490,000. Aphria has a 52 week low of C$4.55 and a 52 week high of C$24.75. The company has a market capitalization of $2,730.00, a PE ratio of 106.00 and a beta of -1.97.
Aphria Inc produces, supplies, and sells medical cannabis in Canada. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.